Skip to Content
Assistant Professor of Ophthalmology and Visual Sciences
Primary Office: 11196 H PFPIowa City, IA 52242 Primary Office Phone: 319-356-8350
Email: elliott-sohn@uiowa.edu
BA, Chemistry, Williams CollegeMD, University of Washington School of Medicine
Internship, Internal Medicine, University of WashingtonResidency, Ophthalmology, University of WashingtonFellowship, Medical Retina, Moorfields Eye HospitalFellowship, Vitreoretinal Surgery, Doheney Eye Institute/USC
State of Iowa, Iowa Board of MedicineAmerican Board of Ophthalmology, American Board of OphthalmologyNational Board of Medical Exminers, National Board of Medical Examiners
Carver Family Center for Macular DegenerationInstitute for Vision Research
Show All
Elimination of infusion bubbles and uncontrolled reflux in the Alcon Constellation Vitrectomy Vision System. Russell S, Sohn E, Boldt C, Folk J, Tarantola R, Kay C, Mahajan V. Retina. 2013 April (2nd Quarter/Spring); 33 (4) :803-806. [Link] Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases. Cunningham M, Tarantola R, Folk J, Sohn E, Boldt C, Graff J, Elkins K, Russell S, Mahajan V. Retina. 2013 March; 33 (3) :579-585. [Link] Retina, Ryan SJ, et al., eds. Sohn E, Mullins R, Stone E. 5th Edition. Saunders/Elsevier; 2013. Macular dystrophies : 852-890.Quantification of external limiting membrane disruption caused by diabetic macular edema from SD-OCT. Chen X, Zhang L, Sohn E, Lee K, Niemeijer M, Chen J, Sonka M, Abramoff M. Invest Ophthalmol Vis Sci. 2012 December; 53 (13) :8042-8048. [Link] Regional corticosteroids for scleritis: Reply. Sohn E, Wang R, Read R, Roufas A, Teo L, Moorthy R, Albini T, Vasconcelos-Santos D, Dustin L, Chee S, Zamir E, McCluskey P, Smith R, Rao N. Ophthalmology. 2012 October (4th Quarter/Autumn); 119 (10) :2199-2200. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment. Report No. 1. Sohn E, He S, Kim L, Salehi-Had H, Javaheri M, Spee C, Dustin L, Hinton D, Eliott D. Arch Ophthalmol. 2012 September; 130 (9) :1127-1134. [Link] Intravitreal bevacizumab for peripapillary choroidal neovascular membranes. Davis A, Folk J, Russell S, Sohn E, Boldt C, Stone E, Mahajan V. Arch Ophthalmol. 2012 August; 130 (8) :1073-1075. [Link] Three dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with Best vitelliform macular dystrophy. Kay C, Abramoff M, Mullins R, Kinnick T, Lee K, Eyestone M, Chung M, Sohn E, Stone E. Arch Ophthalmol. 2012 March; 103 (3) :357-364. [Link] Responsiveness of choroidal neovascular membranes in patients with R345W mutation in fibulin-3 (Doyne honeycomb retinal dystrophy) to anti-vascular endothelial growth factor therapy. Sohn E, Patel P, Maclaren R, Adatia F, Pal B, Webster A, Tufail T. Arch Ophthalmol. 2011 December; 129 (12) :1626-1628. [Link] Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis. Sohn E, Wang R, Read R, Roufas A, Teo L, Moorthy R, Albini T, Vasconcelos-Santos D, Dustin L, Zamir E, Chee S, McCluskey P, Smith R, Rao N. Ophthalmology. 2011 October (4th Quarter/Autumn); 118 (10) :1932-1937. [Link]
Date Last Modified: 04/03/2013 - 11:58:47